GalenusRx

Fernandina Beach, United States Founded: 2023 • Age: 3 yrs
Medication safety risk management solutions are provided for healthcare organizations.
Request Access

About GalenusRx

GalenusRx is a company based in Fernandina Beach (United States) founded in 2023 by Veronique Michaud, Orsula V Knowlton, Jacques Turgeon, and Calvin H Knowlton.. GalenusRx has raised $6.88 million across 1 funding round. GalenusRx offers products and services including APPRAISE Platform and Lifesaving Insights. GalenusRx operates in a competitive market with competitors including House Rx, DecisionRx, Eurekam, Prescription Advisory Systems & Technology and Pillcheck, among others.

  • Headquarter Fernandina Beach, United States
  • Founders Veronique Michaud, Orsula V Knowlton, Jacques Turgeon, Calvin H Knowlton
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Galenusrx, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.88 M (USD)

    in 1 rounds

  • Latest Funding Round
    $6.88 M (USD), Series A

    Aug 30, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of GalenusRx

GalenusRx offers a comprehensive portfolio of products and services, including APPRAISE Platform and Lifesaving Insights. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes drug interactions for personalized risk assessments.

Provides subscription-based medication response analysis and recommendations.

Funding Insights of GalenusRx

GalenusRx has successfully raised a total of $6.88M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.88 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $6.9M
  • First Round

    (30 Aug 2023)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Series A - GalenusRx Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by GalenusRx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - GalenusRx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Galenusrx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of GalenusRx

GalenusRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, DecisionRx, Eurekam, Prescription Advisory Systems & Technology and Pillcheck, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Technology-based medication solutions are provided for patients and caregivers.
domain founded_year HQ Location
Medication management solutions are provided to patients and healthcare providers.
domain founded_year HQ Location
AI-based medication management solutions for oncology professionals are provided.
domain founded_year HQ Location
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
domain founded_year HQ Location
DNA testing platform for user medication responses is offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Galenusrx

Frequently Asked Questions about GalenusRx

When was GalenusRx founded?

GalenusRx was founded in 2023.

Where is GalenusRx located?

GalenusRx is headquartered in Fernandina Beach, United States. It is registered at Fernandina Beach, Florida, United States.

Who is the current CEO of GalenusRx?

Jacques Turgeon is the current CEO of GalenusRx. They have also founded this company.

Is GalenusRx a funded company?

GalenusRx is a funded company, having raised a total of $6.88M across 1 funding round to date. The company's 1st funding round was a Series A of $6.88M, raised on Aug 30, 2023.

What does GalenusRx do?

Founded in 2023, GalenusRx operates in the healthcare sector from Fernandina Beach, United States. A web-based solution is offered to assist clinicians in managing medications for patients with polypharmacy. Risk management tools are focused on enhancing medication safety within healthcare organizations. Operations emphasize real-world applications suited to complex patient needs.

Who are the top competitors of GalenusRx?

GalenusRx's top competitors include House Rx, DecisionRx and Eurekam.

What products or services does GalenusRx offer?

GalenusRx offers APPRAISE Platform and Lifesaving Insights.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available